Since April 2019, I've been operating Gasingil TV on YouTube, aiming to guide those interested in the Korean biotech investment scene. Interestingly, I haven't invested in stocks for the past four years and have no plans to in the future.My motivation to dive into the world of innovative drug development was personal. Both my mother's experience with rheumatoid arthritis and the loss of my grandparents to cancer emphasized the importance of impactful medications. This drove me to offer insights to those exploring investments in Korea's bio sector.Though my academic background is in political science, my focus shifted to the bio-industry. I believe that a robust relationship between this industry and the capital market is vital for growth. My vision has always been on the global stage, but my ultimate goal is to contribute to and witness the steady advancement of the Korean bio-ecosystem.Gasingil TV covers a range of topics in drug development, with a major emphasis on interviews with industry experts. I've managed the entire content production process for about 240 videos by myself. I also regularly share content on Meta (formerly Facebook) and X (previously Twitter), aiming to engage with professionals from various backgrounds in the drug development process.- YouTube [ from April 2019]: www.youtube.com/@GTV406- Meta [from March 2020]: www.facebook.com/gasingiltv- X [from July 2022]: @onco_parkMy key area of focus is oncology. I've virtually attended several annual conferences starting from 2020, using the gathered information to conduct seminars and share insights. My approach to oncology is systematic, breaking down the progression from Indication to Target, Modality, and finally Candidate.Currently, I'm advising Lotte Biologics, mainly focusing on market and industry analysis. Separately, I also offer consultation services to cancer drug developers.I welcome connections from individuals and professionals who share similar interests.
Oncopark (온코파크)
-
Founder Of Oncopark | Oncology Market Analyst | Biotech Strategy ConsultantOncopark (온코파크)Incheon, South Korea
-
Founder & Content CreatorGasingil Tv (가신길Tv) Apr 2019 - PresentSeoul, South Korea
-
Independent ConsultantLotte Biologics Sep 2022 - Sep 2024Seoul, South Korea -
Independent ConsultantGenome & Company Apr 2022 - Mar 2023Seongnam, Gyeonggi, South Korea- Conducted a comprehensive review of significant oncology annual meetings, including AACR, ASCO, ESMO, and SITC.- Synthesized findings from these meetings to deliver actionable insights and strategic recommendations that supported the company's objectives.- Proactively stayed abreast of the latest trends, research, and developments in oncology, enhancing the depth and applicability of the analyses provided. -
ColumnistHitnews Jul 2021 - Jun 2022Seoul, South Korea- Authored in-depth analytical columns focusing on the advancements and trends in the biotech and oncology sectors.- Covered various topics, including the evolution of cancer immunotherapy drugs, insights from significant oncology annual meetings, and analyses of notable companies and announcements in the biotech industry.
Byungjune Park Education Details
-
Bachelor Of Arts (B.A.) In Political Science And Diplomacy
Frequently Asked Questions about Byungjune Park
What company does Byungjune Park work for?
Byungjune Park works for Oncopark (온코파크)
What is Byungjune Park's role at the current company?
Byungjune Park's current role is Founder of OncoPark | Oncology Market Analyst | Biotech Strategy Consultant.
What schools did Byungjune Park attend?
Byungjune Park attended Hanyang University.
Not the Byungjune Park you were looking for?
Free Chrome Extension
Find emails, phones & company data instantly
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial